TB Update for Community Providers in Vermont

Date: June 11, 2019
Location: 1117 Williston Road, South Burlington, VT 05403

COURSE DESCRIPTION & OVERALL GOAL
The purpose of this training is to increase provider awareness and knowledge of TB. Topics will include a review of the current epidemiological trends in TB at the national and local level, regulations and reporting process at the Vermont Department of Health, the role of diagnostic tests for LTBI screening, diagnosis of TB disease, and treatment options for LTBI.

AGENDA

WHO SHOULD ATTEND
This conference is primarily designed for healthcare providers who are involved in the diagnosis, treatment, and management of persons with latent TB infection and disease. The content will be applicable for physicians, physician assistants, nurse practitioners, fellows, and residents. Public health nurses and others working in TB control are welcome to attend.

WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

OBJECTIVES
Upon completion of this conference, participants should be better able to:

  • Recognize the current epidemiological trends in TB at the national and local level and report cases based on the regulations by the Vermont Department of Health.
  • List at least three key services provided by the Vermont TB Program.
  • Select appropriate tests for LTBI screening, diagnosis of TB disease and monitoring patients during treatment.    
  • Implement current recommendations to increase treatment initiation and completion among patients with LTBI.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire meeting, and complete an evaluation. A credit letter will be mailed to participants within 2 months of the meeting. Participants will also be asked to complete a follow-up evaluation within this time frame.

  • CONTINUING EDUCATION INFORMATION
    http://jointaccreditation.org/sites/default/files/Jointly%20Accredited%20Provider%20TM.jpgIn support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the Vermont Department of Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
    CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    CNE: This activity is awarded 5.5 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

    DISCLOSURE POLICY
    All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

    REGISTRATION INFORMATION & FEE
    The registration deadline is May 24, 2019.

    Conference Registration Page

    We reserve the right to close registration early or cancel late registrants due to limits on seating capacity.

    TRAVEL INFORMATION & DIRECTIONS
    The conference will be held at:
    Trader Duke's Hotel
    1117 Williston Road,
    South Burlington, VT 05403

    Directions can be found at: https://www.traderdukeshotelburlingtonvt.com/maps/

    CANCELLATION INFORMATION
    We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.

    FUNDING DISCLOSURE
    Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

    If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Shwata Suresh Kumar at
    ss2980@rutgers.edu

    . 

    FACULTY

    Kemper Alston, MD
    TB Medical Consultant
    Vermont Department of Health


    Sally Cook, RN
    Nurse Consultant
    Vermont Department of Health

    Laura Ann Nicolai, MPH
    TB Control Program Manager
    Vermont Department of Health

    Becky Temple
    Public Health Microbiologist
    Vermont Department of Health

    Edward Zuroweste, MD
    TB Medical Consultant
    Pennsylvania Department of Health

     

     

    PLANNING COMMITTEE

    Kemper Alston, MD
    TB Medical Consultant
    Vermont Department of Health


    Sally Cook, RN
    Nurse Consultant
    Vermont Department of Health

    Anita Khilall, MPH - Activity Director
    Program Director, Education & Training
    Global Tuberculosis Institute

    Laura Ann Nicolai, MPH
    TB Control Program Manager
    Vermont Department of Health

    Shwata Suresh Kumar, MPH
    Health Educator
    Global Tuberculosis Instiute